These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2115231)

  • 1. Inhibition of lipid peroxidation by monoamine oxidase enzyme inhibitors.
    Szökö E; Báthory G; Magyar K
    Acta Physiol Hung; 1990; 75 Suppl():269-70. PubMed ID: 2115231
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of striatal lipid peroxidation induced by 1-methyl-4-phenylpyridinium in mouse brain is blocked by MAO-B inhibitors.
    Ríos C; Bravo-Velazquez S; Altagracia M; Kravzov J
    Proc West Pharmacol Soc; 1994; 37():159-60. PubMed ID: 7984654
    [No Abstract]   [Full Text] [Related]  

  • 3. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term treatment with a monoamine oxidase B inhibitor, selegeline (L-deprenyl), on amino acid transmitter systems in the ageing rat brain.
    Saransaari P; Suhonen J; Lillrank S; Oja SS
    Proc West Pharmacol Soc; 1995; 38():13-7. PubMed ID: 7480005
    [No Abstract]   [Full Text] [Related]  

  • 5. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative damage markers in a renal ischemic-reperfusion model: the protective effect of monoamine oxidase inhibition.
    Troncoso P; Domínguez J; Martínez L; Zambrano N
    Transplant Proc; 1995 Apr; 27(2):1836-8. PubMed ID: 7725528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of the inhibition of monoamine oxidase on daily oscillation of the serotonin content of the brain].
    Montanaro N; Casoli R; Babbini M
    Arch Ital Sci Farmacol; 1965; 15(1):84-6. PubMed ID: 5871028
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain.
    Thiffault C; Quirion R; Poirier J
    Synapse; 1998 Mar; 28(3):208-11. PubMed ID: 9488505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of the chemical structure of monoamine oxidase inhibitors for their effect on the gamma-aminobutyric acid content of the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1967; 18(5):617-24. PubMed ID: 5589667
    [No Abstract]   [Full Text] [Related]  

  • 10. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 2 N-substituted aminotetralin derivatives with antihypertensive action on the monoamine oxidase activity of brain and liver preparations].
    Bogoslovova T; Staneva-Stoĭcheva D
    Eksp Med Morfol; 1987; 26(4):40-4. PubMed ID: 3128443
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors--current status.
    Zemishlany Z; Radwan M; Wijsenbeek H
    Isr J Psychiatry Relat Sci; 1983; 20(3):254-71. PubMed ID: 6325369
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 14. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of central and peripheral carbohydrate reserves after selective inhibition of enzyme monoamine oxidase: comparison between fed and starved rats.
    Parvez H; Ismahan G; Parvez S; Youdim MB
    J Pharmacol; 1981; 12(2):123-33. PubMed ID: 6790875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)Deprenyl (Selegiline): past, present and future.
    Knoll J
    Neurobiology (Bp); 2000; 8(2):179-99. PubMed ID: 11061214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
    Tekes K; Tóthfalusi L; Gaál J; Magyar K
    Pol J Pharmacol Pharm; 1988; 40(6):653-8. PubMed ID: 3152003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of deprenyl on free radical oxidation in rat brain during immobilization stress.
    Tseilikman VE; Sinitsky AI; Poyarkov KA; Vojdaev EV
    Bull Exp Biol Med; 2009 Dec; 148(6):856-8. PubMed ID: 21116490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.